M&A activity remained active as companies continued to make progress on regulatory approvals, financing, shareholder processes, and transaction milestones. Several announced deals advanced through key regulatory reviews, while others moved closer to shareholder votes and expected closing dates. 🔹 Key Deal Developments 🇬🇧 UK CMA Clears PSKY/WBD Transaction The UK Competition and Markets Authority (CMA) cleared the proposed PSKY/WBD transaction, removing an important regulatory hurdle and bringing the deal closer to completion. 💰 AbbVie Advances Apogee Acquisition AbbVie ($ABBV) priced a ~$10 billion senior notes offering to finance its proposed acquisition of Apogee Therapeutics ($APGE). The transaction also cleared key regulatory milestones after the HSR waiting period and reviews in Germany and Austria expired. ✅ Arcline Clears Key Antitrust Milestone Arcline Investment Management's acquisition of AstroNova ($ALOT) advanced after the HSR antitrust waiting period expired, satisfying a major closing condition. 📅 SGI/LEG Merger Remains on Track Management reaffirmed that the all-stock merger between SGI and LEG is expected to close by the end of Q3 2026, subject to customary closing conditions. 🗳️ Olin Urges Shareholder Support Olin ($OLN) reminded shareholders to vote FOR the proposed merger with Huntsman ($HUN) ahead of the upcoming shareholder meeting. 📄 OPFI Updates Shareholder Timeline OppFi ($OPFI) filed an amended Form S-4/A related to its merger with BNCC ($BNCC) and announced a September 17, 2026 shareholder meeting. 🏗️ CRH Reaffirms ACA Acquisition Timeline CRH ($CRH) reiterated that its acquisition of ACA remains on track to close during Q1 2027, subject to remaining regulatory approvals and customary closing conditions. ⏳ ARGX/FBRX Tender Offer Continues The tender offer for $FBRX remains open, with the final expiration date yet to be announced. 📈 Santander Continues Capital Actions Santander ($SAN) released its weekly share buyback transaction report while its previously announced acquisition of Webster Financial ($WBS) continues progressing toward completion. 📌 Market Takeaway Today's M&A activity was led by regulatory approvals, financing updates, and shareholder milestones. The most notable developments included the UK CMA's approval of the PSKY/WBD transaction, AbbVie's $10 billion financing for the Apogee acquisition, and the HSR clearance for Arcline's acquisition of AstroNova, all of which move their respective transactions closer to completion.